Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction-Reference-Cited by-同舟云学术

Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction

Published:2017-04 Issue:4 Volume:56 Page:497-505
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

Meng Qingqing¹²,Lai Yen-Chun¹³,Kelly Neil J.³,Bueno Marta¹³,Baust Jeffrey J.¹,Bachman Timothy N.¹,Goncharov Dmitry¹,Vanderpool Rebecca R.¹,Radder Josiah E.³,Hu Jian¹,Goncharova Elena¹³,Morris Alison M.³,Mora Ana L.¹³,Shapiro Steven D.³,Gladwin Mark T.¹³

Affiliation:

1. Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania

2. School of Medicine, Tsinghua University, Beijing, China

3. Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Reference31 articles.

1. Updated Clinical Classification of Pulmonary Hypertension

2. Heart failure with preserved left ventricular systolic function

3. Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure

4. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure

5. Prevalence and Risk Factors of Pulmonary Hypertension in Patients With Elevated Pulmonary Venous Pressure and Preserved Ejection Fraction

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction;Circulation;2024-09-10

2. Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-07

3. Novel insights into the pathobiology of pulmonary hypertension in heart failure with preserved ejection fraction;American Journal of Physiology-Heart and Circulatory Physiology;2024-06-01

4. A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function;European Journal of Heart Failure;2024-04

5. Ultrasonographic assessment of pulmonary and central venous congestion in experimental heart failure;American Journal of Physiology-Heart and Circulatory Physiology;2024-02-01